Novo Nordisk sees 65% obesity drug sales growth, forecasts $8.14–$9.59B FY25 free cash flow. Click here to read an analysis ...

A retrospective cohort study found that semaglutide and tirzepatide are linked with significantly lower risks of dementia and ...

Wild birds chirp inside a dense grove of magnolia trees shading a new home near downtown Fayetteville. The pale gray two-story Prairie-style single-family residence, appropriately named Magnolia House ...

Older adults and women using Wegovy for obesity management may be more likely to lose lean mass, although increasing protein intake may help protect against lean mass loss, according to a speaker.

Get the 2025 update on the biotech companies Labiotech spotlighted in 2024 — who advanced, who stalled, and who surprised us.

GE HealthCare (Nasdaq: GEHC) has topped a U.S. Food and Drug Administration (FDA) list of AI-enabled medical device authorizations for the fourth year in a row with 100 listed authorizations to date ...

FIRST-HALF BUSINESS FULL-YEAR REVENUES EXPECTED TO EXCEED €40M Bezons, July 23, 2025 - 8:00am - RIBER, the global leader in Molecular Beam Epitaxy (MBE) equipment for the semiconductor industry, ...

Reporting on a non-IFRS basis, the company behind the Concur travel and expense-management platform said total revenue rose 12% at constant currencies to 9.03 billion euros ($10.61 billion) from the ...

Shortly after Samsung’s Galaxy Unpacked event in New York, I had the chance to participate in a dedicated Health Immersion ...

BP named a new board chair after activist shareholders pressured the company to move in a new direction. The London-based ...

Deal-signing at the German cloud computing and software giant SAP turned cautious in the second quarter, CFO Dominik Asam ...

Skyrizi came out with the largest Q2 impressions share of voice (SOV) spot for over-the-counter (OTC) pharma and Rx brands for the second year in a row, according to iSpot.tv data released this week.